ANI Pharmaceuticals Launches Carbamazepine Extended-Release Capsules
Tuesday, April 14, 2026
ANI Pharmaceuticals, Inc. has announced the launch of Carbamazepine Extended-Release Capsules in strengths of 100 mg, 200 mg and 300 mg. The product is a generic version of Carbatrol.
The launch supports the company’s strategy to expand its generics portfolio with limited-competition products. It is also aimed at improving patient access to essential medicines while maintaining quality and regulatory standards.
According to industry data, annual sales for Carbamazepine Extended-Release Capsules in the United States are approximately $65 million as of February 2026.
ANI Pharmaceuticals is a diversified biopharmaceutical company focused on developing, manufacturing and commercialising therapeutic products across rare diseases, generics and branded segments.
Source: globenewswire.com
